The CYP2C19*17 allele is associated with better platelet response to clopidogrel in patients admitted for non-ST acute coronary syndrome

被引：99
作者：
Frere, C. [1 ]
Cuisset, T. [1 ,2 ]
Gaborit, B. [1 ]
Alessi, M. -C. [1 ]
Hulot, J. -S. [3 ]
机构：
[1] CHU Timone, INSERM, Fac Med, Hematol Lab,U626, F-13385 Marseille 05, France
[2] CHU Timone, Dept Cardiol, F-13385 Marseille, France
[3] Hop La Pitie Salpetriere, Unite Pharmacogenet, Serv Pharmacol, Paris, France
来源：
JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2009年 / 7卷 / 08期
关键词：
OF-FUNCTION POLYMORPHISM; INDIVIDUAL RESPONSIVENESS; SEQUENCE VARIATIONS; VARIABILITY; INTERVENTION; REACTIVITY; METABOLISM; COMMON;
D O I：
10.1111/j.1538-7836.2009.03500.x
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：1409 / 1411
页数：3
相关论文
共 13 条
  • [1] Variability in individual responsiveness to clopidogrel - Clinical implications, management, and future perspectives
    Angiolillo, Dominick J.
    Fernandez-Ortiz, Antonio
    Bernardo, Esther
    Alfonso, Fernando
    Macaya, Carlos
    Bass, Theodore A.
    Costa, Marco A.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2007, 49 (14) : 1505 - 1516
  • [2] Contribution of gene sequence variations of the hepatic cytochrome P450 3A4 enzyme to variability in individual responsiveness to clopidogrel
    Angiolillo, Dominick J.
    Fernandez-Ortiz, Antonio
    Bernardo, Esther
    Ramirez, Celia
    Cavallari, Ugo
    Trabetti, Elisabetta
    Sabate, Manel
    Hernandez, Rosana
    Moreno, Raul
    Escaned, Javier
    Alfonso, Fernando
    Banuelos, Camino
    Costa, Marco A.
    Bass, Theodore A.
    Pignatti, Pier Franco
    Macaya, Carlos
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2006, 26 (08) : 1895 - 1900
  • [3] Cytochrome P450 2C19 polymorphism in young patients treated with clopidogrel after myocardial infarction: a cohort study
    Collet, Jean-Philippe
    Hulot, Jean-Sebastien
    Pena, Anna
    Villard, Eric
    Esteve, Jean-Baptiste
    Silvain, Johanne
    Payot, Laurent
    Brugier, Delphine
    Cayla, Guillaume
    Beygui, Farzin
    Bensimon, Gilbert
    Funck-Brentano, Christian
    Montalescot, Gilles
    [J]. LANCET, 2009, 373 (9660) : 309 - 317
  • [4] Effect of cytochrome P450 polymorphisms on platelet reactivity after treatment with Clopidogrel in acute coronary syndrome
    Frere, Corinne
    Cuisset, Thomas
    Morange, Pierre-Emmanuel
    Qpilici, Jacques
    Camoin-Jaumd, Laurence
    Saut, Noemie
    Faille, Dorothee
    Lambert, Marc
    Juhan-Vague, Irene
    Bonnet, Jean-Louis
    Alessi, Marie-Christine
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2008, 101 (08) : 1088 - 1093
  • [5] Cytochrorne P4502C19 loss-of-function polymorphism is a major determinant of clopidogrel responsiveness in healthy subjects
    Hulot, Jean-Sebastien
    Bura, Alessandra
    Villard, Eric
    Azizi, Michel
    Remones, Veronique
    Goyenvalle, Catherine
    Aiach, Martine
    Lechat, Philippe
    Gaussem, Pascale
    [J]. BLOOD, 2006, 108 (07) : 2244 - 2247
  • [6] Cytochrome P-450 Polymorphisms and Response to Clopidogrel.
    Mega, Jessica L.
    Close, Sandra L.
    Wiviott, Stephen D.
    Shen, Lei
    Hockett, Richard D.
    Brandt, John T.
    Walker, Joseph R.
    Antman, Elliott M.
    Macias, William
    Braunwald, Eugene
    Sabatine, Marc S.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (04) : 354 - 362
  • [7] IMPORTANCE OF HEPATIC-METABOLISM IN THE ANTIAGGREGATING ACTIVITY OF THE THIENOPYRIDINE CLOPIDOGREL
    SAVI, P
    HERBERT, JM
    PFLIEGER, AM
    DOL, F
    DELEBASSEE, D
    COMBALBERT, J
    DEFREYN, G
    MAFFRAND, JP
    [J]. BIOCHEMICAL PHARMACOLOGY, 1992, 44 (03) : 527 - 532
  • [8] SAVI P, 1994, J PHARMACOL EXP THER, V269, P772
  • [9] Cytochrome P450 2C19 loss-of-function polymorphism and stent thrombosis following percutaneous coronary intervention
    Sibbing, Dirk
    Stegherr, Julia
    Latz, Wolfgang
    Koch, Werner
    Mehilli, Julinda
    Doerrler, Katharina
    Morath, Tanja
    Schoemig, Albert
    Kastrati, Adnan
    von Beckerath, Nicolas
    [J]. EUROPEAN HEART JOURNAL, 2009, 30 (08) : 916 - 922
  • [10] A common novel CTP2C19 gene variant causes ultrarapid drug metabolism relevant for the drug response to proton pump inhibitors and antidepressants
    Sim, SC
    Risinger, C
    Dahl, ML
    Aklillu, E
    Christensen, M
    Bertilsson, L
    Ingelman-Sundberg, M
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2006, 79 (01) : 103 - 113
12